Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-098259
Filing Date
2024-08-19
Accepted
2024-08-19 06:04:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3719
  Complete submission text file 0000950170-24-098259.txt   5266
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Modig Berndt (Reporting) CIK: 0001643072 (see all company filings)

Type: 144

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Subject) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40010 | Film No.: 241218172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)